ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Dual human epidermal growth factor receptor 2 (HER2) blockade and hormonal therapy for the treatment of primary HER2-positive breast cancer: one more step toward chemotherapy-free therapy.

Aleix Prat et al.PubMed ↗Publisher ↗

No numbers read from the abstract.